Categories » Home Care Products
Quintessence® Skin Brightener is a light, easily absorbed cream designed as an alternative to high strength hydroquinone formulations for improving the appearance of facial and hand pigmentation. It can be used for long term face and hand brightening as well as for evening out skin tone. It also possesses excellent moisturizing and antioxidant properties. Quintessence® Skin Brightener is appropriate for all skin types.
· Gradual, uniform lightening
· Extremely low cytotoxicity allowing it to be used over extended periods of time (i.e., years)
· High tyrosinase inhibitor levels
PHENYLETHYL RESORCINOL): Potent skin lightener and anti-oxidant that is non-irritating with extremely low cytotoxicity. Studies demonstrate it has in vitro anti-oxidant efficacy equivalent to Alpha Tocopherol (Vit. E). Effectiveness Study conducted on 12 Asian subjects (skin type III) showed 0.5% Phenylethyl Resorcinal more effective than 1.0% Kojic Acid.
Myristoyl Pentapeptide-9: Propietary Lipopeptide that provides anti-wrinkle benefits, while both brightening and helping give the skin a more even tone.
ARBUTIN: Naturally found in the leaves of pear trees and certain herbs, Arbutin reverses rather than suppresses tyrosinase activity. It functions as a melanogenesis inhibitor to reduce the appearance of hyperpigmentation and is an effective antioxidant and skin conditioner.
Directions for use: After cleansing with Quintessence Purifying Cleanser, apply Quintessence Skin Brightener to problem areas for one month prior to full face/hand application. After problems areas have lightened to desired color, Quintessence Skin Brightener may be applied to entire area to achieve an even color.
2. Yokoto T, Nishio H, Kubota Y et el: The inhibitory effect of glabridrin from licorice extract on melanogenisis and inflamation. Pigment Cell Res 11:355, 1998
4. Nakagama M, Kawai K, Kawai K: Contact Allergy to Kojic Acid in Skin Care Products. Contact Dermatitis 32:9, 1995
6. Kasrae B: Peroxidase-Mediated Mechanisms and Depigmenting Agents; Dermatology 2002;205:329–339
« Previous | Next »